Scientific Programme

Scientific Programme

Monday 27th

Monday 27th March
9:00 – 13:00 Banff Pre-meeting: New endpoints for Next Generation Clinical Trials
Chairs: Denis Glotz, Peter Nickerson
  • Welcome and opening Remarks: History and Future of the Banff Classification, Where the Present Lesion Scoring Criteria Came From, and the Continued Need for Ease of Use and Time Efficiency
    Kim Solez, Alberta, Canada
  • A tribute to Daniel R. Salomon (1953-2016)
    Kim Solez, Alberta, Canada
  • Next Generation Clinical Trials: how the Banff classification needs to support these
    Kim Solez, Alberta, Canada
  • DSA-monitoring as an end point
    Anat Tambur, Chicago, USA
  • Refined histology scoring as a reliable endpoint
    Bob Colvin, Boston, USA

10:45 – 11:15: Coffee break

  • The Molecular Microscope as an endpoint
    Philip Halloran, Alberta, Canada
  • Clinical trials: the FDA unmet needs
    Mark Stegall, Rochester, USA
  • Potential endpoints for response to treatment of ABMR in heart transplant recipients
    Luciano Potena, Bologna, Italy
13:00 – 14:00 Lunch break
14:00 – 15:00 Industry Symposium 1
15:00 – 17:30 Banff Pre-meeting: New endpoints for Next Generation Clinical Trials
Chairs: Denis Glotz, Peter Nickerson
  • Potential endpoints for response to treatment of ABMR in liver transplant recipients
    Sandy Feng, San Francisco, USA
  • Potential endpoints for response to treatment of ABMR in kidney transplant recipients
    Mark Stegall, Rochester, USA
  • Optimizing Statistical methods for generating robust endpoints
    Dorry Segev, Baltimore, USA
  • Adopting a histo-immuno-clinico-laboratory composite endpoint: The iBox
    Alexandre Loupy, Paris, France
  • Group Discussion
19:00 – 20:00 BANFF BOT MEETING

Tuesday 28th

Wednesday 29th

Thursday 30th

Friday 31st